<div role="article" aria-roledescription="email" style="-webkit-text-size-adjust: 100%;-ms-text-size-adjust: 100%;padding: 20px 0px;margin: 0 auto;"><div style="height:0px;max-height:0px;border-width:0px;border: 0px;border-color:initial;border-image:initial;visibility:hidden;line-height:0px;font-size:0px;overflow:hidden;display:none;"></div><table id="$beacon$"><tbody><tr><td></td></tr></tbody></table><table id="stb-container" role="presentation" style="width:100%;" border="0" bordercolor=""><tbody><tr><td align="center"><!--[if mso]> <table role="presentation" align="center" style="width:630px;background:#ffffff;"> <tr> <td> <div class="outer"> <![endif]--><!--[if !mso]><!--><div class="outer" style="width:100%;max-width:630px;background:#ffffff;margin: 0px auto;"><!--<![endif]--><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box" style="padding:0 0;text-align:left;margin:0px;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%" class="stb-permalink"><tbody><tr><td style="padding:5px 15px 5px 15px;"><div><span style="font-weight: bold; font-style: italic;" class="stb-bold stb-italic">2026-02-26 </span></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:15px 15px 0 15px;"><a href="https://www.brpinsight.com/" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3255129_1772076658653408005.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="600" class="stb-center"></a></td></tr><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:20px 15px 15px 15px;"><div style="text-align: center;"> <span style="font-size: 20px;"><span class="stb-bold" style="font-weight: bold;">🔎</span></span><br><span class="link-edited stb-bold" style="font-size: 16px; font-weight: bold;">"데이터로 읽는 시장의 흐름, BRPInsight가 엄선했습니다"</span></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#F2E7FD;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div style="text-align: center;"><span style="font-weight: bold; font-size: 18px;" class="stb-bold">✨ Only BRPInsight </span></div></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div><span style="font-weight: bold; color: #722ed1; font-size: 18px;" class="stb-bold stb-fore-colored">📈 꾸준히 성장 중인 전립선비대증 시장…돋보이는 '탐스로신'</span></div><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>인구 고령화 등에 따라 전립선비대증 환자가 늘면서 국내 관련 치료제 시장이 꾸준히 성장하고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>2025년 국내 전립선비대증 치료제 시장 규모는 약 1조 2,504억 원이며, 이 중 '탐스로신' 성분은 전체 시장의 약 40%를 차지하고 있습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>성장세에 있는 전립선비대증 치료제 시장과 2025년 전립선비대증 치료제 시장 TOP5 제품에 대해 BRP인사이트에서 확인해 보세요.🔎</li></ul><div><br></div></td></tr><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><a href="https://www.brpinsight.com/contents-center/2911" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3255129_1772083201643911142.png" alt="" style="width:590px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="590" class="stb-center"></a></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #722ED1;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/contents-center/2911" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">상세 리포트 보러 가기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div style="text-align: center;"><span style="font-weight: bold; font-size: 18px;" class="stb-bold">📰 Daily News Clip </span></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div><span style="font-weight: bold;" class="stb-bold">☑️ <span style="font-size: 16px;">삼일 글립타이드, 위염 대조약 대비 비열등성 입증 실패<a href="https://dailypharm.com/user/news/335998" target="_blank" style="color: #ff5252; text-decoration: underline;">🔗</a></span></span></div><div><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="color: ; font-size: 16px;'"><span style="font-size: 16px;">삼일제약 글립타이드정200mg(설글리코타이드)가 재평가 임상시험에서 1차 평가변수를 충족하지 못한 것으로 나타났습니다.</span></li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="color: ; font-size: 16px;'"><span style="font-size: 16px;">회사 측은 당뇨환자를 제외하면 대조약과 차이가 크지 않다며 유효성이 없다고 보기 어렵다는 입장을 나타냈습니다.</span></li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li style="color: ; font-size: 16px;'"><span style="font-size: 16px;">식약처는 이 약에 대한 효능·효과를 삭제할 계획인데, 현재 업체 의견을 청취하는 절차를 거치고 있는 것으로 파악됩니다. 식약처 방안대로라면 이 약은 효능·효과가 전부 삭제돼 사실상 시장에서 퇴출될 전망입니다.</span></li></ul><span style="font-size: 12px;"></span></div><div style="text-align: right;"><span style="font-size: 12px;">[데일리팜ㅣ26.02.26]</span><br></div></td></tr><tr><td style="text-align:center;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><img src="https://img2.stibee.com/440332_3255129_1772083215138719542.jpg" alt="" style="width:590px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="590" class="stb-center"></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #F1F3F5;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/502" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">퇴출 위기, 삼일제약 '글립타이드'에 대해 알아보기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 0 15px;"><div>☑️ <span style="font-weight: bold;" class="stb-bold">'트루셋' 제네릭 대전 본격화, 제뉴파마 '텔로핀셋정' 출사표<a href="https://www.hitnews.co.kr/news/articleView.html?idxno=74168" class="stb-underline" style="font-weight: normal; font-style: normal; text-decoration: underline; color: #ff5252;" target="_blank">🔗</a> </span></div><div> </div><div><ul style="padding: 0; margin: 0 0 0 30px;"><li>제뉴원사이언스의 자회사 제뉴파마는 3월 1일 3제 고혈압 복합제 '텔로핀셋정'(성분명 텔미사르탄/암로디핀베실산염/클로르탈리돈)을 출시한다고 26일 밝혔습니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>텔로핀셋은 안지오텐신II 수용체 차단체(ARB) 계열의 텔미사르탄, 칼슘 채널 차단제(CCB) 계열의 암로디핀베실산염, 이뇨제인 클로르탈리돈의 세 가지 성분을 결합한 단일제형 고혈압 3제 복합제입니다.</li></ul><div><br></div><ul style="padding: 0; margin: 0 0 0 30px;"><li>이번 '텔로핀셋정' 출시를 통해 텔미사르탄 기반 만성질환 치료제 포트폴리오를 강화하고 관련 매출 성장을 가속화한다는 계획입니다.</li></ul><div style="text-align: right;"><span style="font-size: 12px;">[히트뉴스ㅣ26.02.26]</span></div></div></td></tr><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:20px 15px 0 15px;"><img src="https://img2.stibee.com/440332_3255129_1772083872102689671.jpg" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="600" class="stb-justify"></td></tr><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:20px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#F1F3F5;mso-padding-alt:0px;background:#722ED1;border-radius:500px;border:2px solid #722ED1;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/distributor/183" style="font-size:16px;display:inline-block;color:#F1F3F5;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank">'트루셋' 제네릭 대전에 뛰어든 '제뉴파마'에 대해 알아보기</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#F2E7FD;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:15px 15px 15px 15px;"><div><span style="font-size: 18px; font-weight: bold;" class="stb-bold">🔎 더 많은 시장 인사이트가 궁금하다면? </span></div></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2503" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">📉 [2025 ETC 시장] -20%의 충격, 항생제 시장은 왜 추락했나? </a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;background:#ffffff;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2505" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">🔥 [2025 ETC 시장] 비만 치료제 시장, 사실상 '그들'만의 2파전 리그</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:dashed;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:left;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#722ED1;mso-padding-alt:0px;background:#ffffff;border-radius:500px;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:19px 20px;text-align:left;" valign="top"><a href="https://www.brpinsight.com/contents-center/2811" style="font-size:16px;display:inline-block;color:#722ED1;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:left;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank">✨ [2025 OTC 시장] 대세 약국 화장품, 전년 대비 257% 성장한 브랜드는?</a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:25px 15px 25px 15px;"><a href="https://www.brpinsight.com/" target="_blank" style="text-decoration: underline; color: #ff5252;"><img src="https://img2.stibee.com/440332_3255129_1772085216974426135.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="600" class="stb-justify"></a></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box stb-permalink stb-footer" style="text-align:center;margin:0px;;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;border:0;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="padding:15px 15px 15px 15px;text-align:center;"><div><span class="stb-fore-colored" style="color: #959595;">BRPInsight</span></div><div>brpnews@brpinsight.com<br><span class="stb-fore-colored" style="color: #959595;">(주)BRP커넥트ㅣ서울시 동작구 동작대로 77(사당동)ㅣ</span><br><span class="stb-fore-colored" style="color: #959595;"><a href="$%unsubscribe%$" class="stb-fore-colored stb-underline" style="text-decoration: underline; color: #959595;" target="_blank"><span style="font-weight: normal; font-style: normal;">수신거부</span></a> <a href="$%unsubscribe%$" class="stb-fore-colored stb-underline" style="text-decoration: underline; color: #959595;" target="_blank"><span style="font-weight: normal; font-style: normal;">Unsubscribe</span></a></span></div></td></tr></tbody></table></td></tr></tbody></table></div><!--[if mso]> </td> </tr> </table> <![endif]--></td></tr></tbody></table><div style="padding: 10pt 0cm 10pt 0cm;"><p class="MsoNormal" align="center" style="text-align: center;"><span lang="EN-US"></span></p></div></div>